Anti‐neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti‐cathepsin G and a novel antibody correlate with a refractory type

We analysed the clinical significance of ANCA in patients with ulcerative colitis. On either an indirect immunofluorescence assay or an ELISA with fixed neutrophils, 71% (25/35) of the patients were positive for ANCA. However, only half of them reacted with either cathepsin G or lactoferrin. Western blot assays revealed positive bands in 40% (10/25) of the antibody‐positive patients. The sizes of the bands detected were ≈58, 47, 44, 40, and 28 kD. No significant correlation was found between the ANCA positivity and various variables, i.e. disease activity, extent of lesion, or treatment of the disease. The anti‐cathepsin G and 28‐kD positivity, however, significantly correlated with a refractory type of ulcerative colitis.

[1]  A. Amoroso,et al.  Antineutrophil cytoplasmic antibodies in ulcerative colitis , 1995 .

[2]  C. Kallenberg,et al.  Anti‐neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates , 1994, Clinical and experimental immunology.

[3]  W. Brown,et al.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. , 1994, Gut.

[4]  J. Grünfeld,et al.  Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations. , 1993, Journal of Autoimmunity.

[5]  R. Goldschmeding,et al.  Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. , 1993, Gut.

[6]  G. Bodemar,et al.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. , 1993, Gut.

[7]  A. D'apice,et al.  Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease. , 1992, Australian and New Zealand journal of medicine.

[8]  J. Grünfeld,et al.  Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis , 1992, Clinical and experimental immunology.

[9]  S. Targan,et al.  Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. , 1992, Gastroenterology.

[10]  H. Rieder,et al.  Antibodies to Cathepsin G in Crohn's disease , 1992, European journal of clinical investigation.

[11]  M. Kamm,et al.  Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. , 1992, Gut.

[12]  F. Seibold,et al.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.

[13]  F. Seibold,et al.  Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis , 1991, Hepatology.

[14]  S. Targan,et al.  Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. , 1991, Gastroenterology.

[15]  R. Wiesner,et al.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. , 1991, Gastroenterology.

[16]  S. Targan,et al.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.

[17]  R. Falk,et al.  Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. , 1989, Clinical immunology and immunopathology.

[18]  A. Wiik.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. , 1989, APMIS. Supplementum.

[19]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[20]  H. L. MacKechnie.  The immunology of inflammatory bowel disease. , 1982, Henry Ford Hospital medical journal.